Interleukin-12 (IL-12) enhances lysis of non-lymphoid leukemia cell lines in vitro

Leukemia

Volumn 12, Issue 8, 1998, Pages 1204-1209

  Stine, K C ^a   Warren, B A ^a   Becton, D L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Acute myeloid leukemia; IL 12; IL 2; Natural killer cells

Indexed keywords

GAMMA INTERFERON; INTERFERON ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 2;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMIUM 51 RELEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOLYSIS; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; LEUKEMIA CELL LINE; MINIMAL RESIDUAL DISEASE; NATURAL KILLER CELL; NONLYMPHATIC LEUKEMIA; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0031854740     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401085     Document Type: Article

References (20)

1. Buckley JD, Chard RL, Baehner RL, Nesbit ME, Lampkin BC, Woods WG, Hammond CD. Improvement in outcome for chil-dren with acute nonlymphocytic leukemia. A report from the Childrens Cancer Study Group. Cancer 1989; 63: 1457-1465.
2. Brown RA, Wolff SN, Fay JW, Pineiro L,Collins RH Jr, Lynch JP, Stevens D, Greer J, Herzig RH, Herzig GP. High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American marrow transplant group. Blood 1995; 85: 1391-1395.
3. Foa R. Does interleukin-2 have a role in the management of acute leukemia? J Clin Oncol 1993; 11: 1817-1825.
4. Simonsson B, Nilsson BI, Rowe JM. Treatment of minimal residual disease in acute leukemia - focus on immunotherapeutic options. Leukemia 1992; 6: S124-S134.
5. Sznol M, Parkinson DR. Interleukin-2 in therapy of hematologic malignancies. Blood 1994; 83: 2020-2022.
6. Meloni G, Foa R, Vignetti M, Guarini A, Fenu S, Tosti S, Tos AG, Mandelli F. Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemia. Blood 1994; 84: 2158-2163.
7. Manetti R, Gerosa F, Giudizi MG, Biagiotti R, Parronchi P, Piccinni MP, Sampognaro S, Maggi E, Romagnani S, Trinchieri G. Interleukin-12 induces stable priming for Interferon gamma production during differentiation of human T helper (Th) cells and transient IFN gamma production in established TH2 cell clones. J Exp Med 1994; 179: 1273-1283.
8. Wolf SF, Sieburth D, Sypek J. Interleukin-12: a key modulator of immune function. Stem Cells 1994; 12: 154-168.
9. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK. Antitumor and antimetastatic activity of interleukin-12 against murine tumors. J Exp Med 1993; 178: 1223-1230.
10. Zitvogel L, Tahara H, Robbins PD, Storkus WJ, Clarke MR, Nalesnik MA, Lotze MT. Cancer immunotherapy of established tumors with IL-12: effective delivery by genetically engineered fibroblasts. J Immunol 1995; 155: 1393-1403.
11. Rossi AR, Pericle F, Rashleigh S, Janiec J, Djeu JY. Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12. Blood 1994; 83: 1323-1328.
12. Cesano A, Visonneau S, Cioe L, Clark SC, Rovera G, Santoli D. Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer approach. J Clin Invest 1994; 94: 1076-1084.
13. Uharek L, Glass B, Steinmann J, Dreger P, Gussmann W, Schmitz N, Muller-Rucholtz W. High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2. Leukemia 1996; 10: 1758-1764.
14. Chan SH, Kobayashi M, Santoli D, Perussia B, Trinchieri G. Mechanism of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12). J Immunol 1992; 148: 92-98.
15. Desai BB, Quinn PM, Wolitzky AC, Mongini PKA, Chizzonite R, Gately MK. IL-12 receptor II. Distribution and regulation of receptor expression. J Immunol 1992; 148: 3125-3132.
16. Johnston JA, Bacon CM, Riedy MC, O'Shea JJ. Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency. J Leuk Biol 1996; 60: 441-4452.
17. Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 1995; 268: 251-255.
18. Leonard JP, Sherman ML, Fisher GL, Buchanan LJ, Larsen G, Atkins MB, Sosman JA, Dutcher JP, Vogelzang NJ, Ryan JL. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood 1997; 90: 2541-2548.
19. Ross ME, Caligiuri MA. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 1997; 89: 910-918.
20. Gottlieb DJ, Prentice HG, Heslop HE, Bello-Fernandez C, Bianchi AC, Galazka AR, Brenner MK. Effects of recombinant IL-2 administration on cytotoxic function following high-dose chemo-radiotherapy for hematologic malignancy. Blood 1989; 74: 2335-2342.